Skip to main content
DVA
NYSE Industrial Applications And Services

DaVita Q2 Earnings Beat, Raises Full-Year EPS Guidance to $14.10-$15.20

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$211.9
Mkt Cap
$14.637B
52W Low
$101
52W High
$247.49
52W Position info
110% above low
Off High info
14% below high
Rel. Volume info
2.9× avg
Market data snapshot near publication time

DVA has more than doubled off its 52-week low of $101 on elevated volume (2.9× avg).

Summary

DaVita reported Q2 2026 earnings that beat expectations, raised full-year EPS guidance above consensus, and continued aggressive share buybacks, signaling strong operational momentum.


Key Events · Earnings and Guidance · DVA

  • Q2 Earnings Beat

    Net income of $265.4M ($4.02 diluted EPS) vs. $199.3M ($2.58) a year ago; revenue rose to $3.554B from $3.380B.

  • Raised Full-Year Guidance

    Adjusted diluted EPS guidance raised to $14.10-$15.20, above consensus; free cash flow guidance increased to $1.0B-$1.25B.

  • Aggressive Share Repurchases

    2.2M shares repurchased in Q2 at avg $154.95; additional 0.2M shares bought post-quarter at avg $199.55, totaling $385M.

  • Debt Refinancing

    Entered $500M incremental Term Loan B-2 in June 2026; proceeds used to repay revolver and for general corporate purposes.


Analysis · DVA · Industrial Applications And Services

DaVita delivered a strong Q2, with net income surging to $265.4 million ($4.02/share) from $199.3 million a year ago, driven by revenue growth and margin expansion. The company raised its full-year adjusted EPS guidance to $14.10-$15.20, above consensus, and boosted free cash flow expectations to $1.0-$1.25 billion. Aggressive share repurchases continued — 2.2 million shares bought in Q2 at an average $154.95, with another 0.2 million shares bought post-quarter near $200. The $500 million incremental term loan refinancing strengthens the balance sheet. Against a backdrop of recent insider selling, these results and the raised outlook signal operational momentum and confidence in capital returns.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DVA was trading at $211.90 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $14.6B. The 52-week trading range was $101.00 to $247.49. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DVA - Latest Insights

DVA
Nov 10, 2026, 12:42 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $180.24
Real-time Price: $174.00 info
Change: -$6.24 (-3%) info
Market Cap: $10.958B info
DVA
Oct 29, 2026, 5:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $180.00
Real-time Price: $174.00 info
Change: -$6.00 (-3%) info
Market Cap: $10.958B info
DVA
Oct 29, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $184.00
Real-time Price: $174.00 info
Change: -$10.00 (-5%) info
Market Cap: $10.958B info
DVA
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $193.31
Real-time Price: $174.00 info
Change: -$19.31 (-10%) info
Market Cap: $10.958B info
DVA
Sep 04, 2026, 10:56 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $182.70
Real-time Price: $174.00 info
Change: -$8.70 (-5%) info
Market Cap: $10.958B info